openPR Logo
Press release

Rising incidences of CVD is accelerating the Global Myocardial Infarction Treatment Market | Market Opportunities and Forecast, 2018-2023 | Major Companies: AstraZeneca PLC, Merck KGaA, Johnson & Johnson, Pfizer, Inc., Novartis International AG, GlaxoSmit

03-13-2019 12:22 PM CET | Health & Medicine

Press release from: Orion Market Research

Orion Market Research

Orion Market Research

Orion Market Research (OMR) recently published a market research report on the global myocardial infarction treatment market. According to OMR analysis, the global myocardial infarction treatment market is estimated to grow at a significant CAGR during the forecast period (2018-2023). The crucial factors contributing to the growth of the global myocardial infarction treatment market include rising incidence rate of CVD (cardiovascular disease) and intake of high-level sugary food, which significantly increased the prevalence of CADs (coronary artery diseases). Moreover, the shift towards sedentary lifestyle and faulty dietary habits coupled with lack of physical activity are some other factors fueling the growth of the market. However, the high cost of myocardial infarction treatment and delay in certification and approval for heart treatment are some factors restraining the growth of the market.

A full report of global myocardial infarction treatment market is available at https://www.omrglobal.com/industry-reports/myocardial-infarction-treatment-market/

Furthermore, the global myocardial infarction treatment market is segmented on the basis of type, device, diagnosis, treatment and end-users. The report provides detailed & insightful chapters which include market overview, key findings, strategic recommendations, market estimations, market determinants, key company analysis, market insights, company profiling, market segmentation, geographical analysis, analyst insights and predictive analysis of the market.

Market Segmentation

1. Global Myocardial Infarction Treatment Market by Type
• ST-Segment Elevation Myocardial Infarction (STEMI) Heart Attacks
• Non-ST Segment Elevation Myocardial Infarction (NSTEMI) Heart Attacks
• Silent Heart Attacks

2. Global Myocardial Infarction Treatment Market by Device
• Left Ventricular Assist Device
• Pacemaker
• Implantable Cardioverter Defibrillator
• Others (Aspiration-Based Catheters)

3. Global Myocardial Infarction Treatment Market by Diagnosis
• Electrocardiography (ECG)
• Chest X-Ray
• Computed Tomography (CT Scan)
• Echocardiography
• Others (Blood Test)

4. Global Myocardial Infarction Treatment Market by Treatment
• Medication
o Analgesics
o Thrombolytic
o Antiplatelet Agents
o Glycoprotein IIb/IIIa Inhibitors
o Others (Adrenergic Blockers)
• Surgery
o Angioplasty
o Bypass Surgery
o Heart Transplant
5. Global Myocardial Infarction Treatment Market by End-Users
• Hospital & Clinics
• Ambulatory Surgical Centers
• Research Institutes

Regions Covered

• North America (the US and Canada)
• Europe (UK, Germany, France, Spain, and Italy)
• Asia-Pacific (China, India, South Korea, and Japan)
• Rest of the World (Middle East & Africa and Latin America)

Company Profiles

• advanceCOR GmbH
• Anthera Pharmaceuticals, Inc.
• AstraZeneca PLC
• Athersys, Inc.
• Bayer AG
• BioVascular, Inc.
• Boehringer Ingelheim International GmbH
• BRISTOL-MYERS SQUIBB Co.
• Caladrius Biosciences, Inc.
• Capricor Therapeutics, Inc.
• CSL Behring
• GlaxoSmithKline PLC
• GNT Pharma Co., Ltd
• Johnson & Johnson
• Merck KGaA
• Mesoblast Ltd.
• Mylan N.V.
• NeuroVive Pharmaceutical AB
• Novartis International AG
• Osiris Therapeutics, Inc.
• Pfizer, Inc.
• PledPharma AB
• Portola Pharmaceuticals, Inc.
• Sandoz International GmbH
• Sanofi SA
• Teva Pharmaceutical Industries Ltd.
• Ventrix, Inc.

For related reports please visit https://www.omrglobal.com/reports-category/medical-devices/

For more update follow LinkedIn https://www.linkedin.com/company/omr-global-research/

About Orion Market Research

Orion Market Research (OMR) a research company known for its crisp and concise reports. The company is equipped with an experienced team and young brigade of analysts. The company aims to provide business insights for decision making to the global clients and offers quality syndicated research reports, customized research reports, Company profiling, consulting and other research-based services. OMR provide global and regional market reports of various domains such as healthcare, energy, IT, chemicals, and automobiles. OMR provide a 360-degree view of the market with parametric analysis, key market insights, key findings, statistical forecasts, competitive landscape, extensive segmentation, key trends, strategic recommendations and detailed company profiles.

Contact us

Orion Market Research Pvt. Ltd.
Anurag Tiwari
Email: info@omrglobal.com
India: +91 7803040404
Global:+1 6467557667
Indore-India-452010
Web: www.omrglobal.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Rising incidences of CVD is accelerating the Global Myocardial Infarction Treatment Market | Market Opportunities and Forecast, 2018-2023 | Major Companies: AstraZeneca PLC, Merck KGaA, Johnson & Johnson, Pfizer, Inc., Novartis International AG, GlaxoSmit here

News-ID: 1651418 • Views: …

More Releases from Orion Market Research

Workplace Safety Market Set to Witness Significant Growth by 2033 | MSA Safety Incorporated, Ansell Limited, Drägerwerk AG & Co. KGaA
Workplace Safety Market Set to Witness Significant Growth by 2033 | MSA Safety I …
The Workplace Safety market was valued at approximately USD 16.2 billion in 2024 and is projected to reach around USD 49.4 billion by 2033, growing at a compound annual growth rate (CAGR) of 13.20% from 2025 to 2033. Workplace Safety Market Overview The global Workplace Safety market is experiencing significant growth, driven by increasing awareness of occupational hazards, stricter regulations, and a heightened focus on employee well-being. Employers are emphasizing…
Waste Sorting Robots Market Set to Witness Significant Growth by 2033 | Bulk Handling Systems (BHS), Sadako Technologies
Waste Sorting Robots Market Set to Witness Significant Growth by 2033 | Bulk Han …
The global Waste Sorting Robots market was valued at approximately USD 2.13 billion in 2024 and is projected to reach around USD 10.66 billion by 2033, growing at a compound annual growth rate (CAGR) of 19.6% from 2025 to 2033. Waste Sorting Robots Market Overview The global Waste Sorting Robots market is experiencing significant growth, driven by increasing environmental concerns, stringent waste management regulations, and the need for efficient and cost-effective…
Food Blenders & Mixers Market Set to Witness Significant Growth by 2034 | Bühler Group, John Bean Technologies (JBT), and KHS Group
Food Blenders & Mixers Market Set to Witness Significant Growth by 2034 | Bühl …
The global Food Blenders & Mixers market was valued at approximately USD 10.08 billion in 2024 and is projected to reach around USD 19.29 billion by 2034, expanding at a compound annual growth rate (CAGR) of 6.70% from 2025 to 2034. Food Blenders & Mixers Market Overview The global Food Blenders & Mixers market is experiencing significant growth, driven by advancements in food processing technologies and increasing consumer demand for convenience…
Artificial Intelligence (AI) in Cybersecurity Market Set to Witness Significant Growth by 2033 | FireEye, Inc., Check Point Software Technologies Ltd
Artificial Intelligence (AI) in Cybersecurity Market Set to Witness Significant …
The global Artificial Intelligence (AI) in Cybersecurity market was valued at approximately USD 25.35 billion in 2024. its robust expansion, with estimates suggesting it could attain USD 240.42 billion by 2033, reflecting a CAGR of 26.3% from 2025 to 2033. Artificial Intelligence (AI) in Cybersecurity Market Overview The AI in Cybersecurity market is experiencing rapid growth due to the increasing sophistication of cyber threats and the need for advanced defense mechanisms.…

All 5 Releases


More Releases for Myocardial

Driving Myocardial Infarction Market Growth in 2025: The Role of Increasing Numb …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. Myocardial Infarction Market Size Growth Forecast: What to Expect by 2025? Over the past few years, there has been a significant rise in the size of the myocardial infarction market. It is projected to expand from $2.05 billion in 2024 to $2.2 billion in 2025, exhibiting a compound annual…
Diabetes Epidemic Fuels Myocardial Ischemia Market Growth: An Emerging Driver Tr …
The Myocardial Ischemia Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. What Is the Projected Growth of the Myocardial Ischemia Market? The myocardial ischemia market has grown strongly. It will grow from $0.79 billion in 2024 to $0.85 billion in 2025 at a CAGR of 7.3%.…
Transforming the Myocardial Ischemia Market in 2025: Diabetes Epidemic Fuels Myo …
What Is the Expected Size and Growth Rate of the Myocardial Ischemia Market? The market size for myocardial ischemia has demonstrated considerable growth over the last few years. There's a predicted growth from $0.79 billion in 2024 to $0.85 billion in 2025, with a compound annual growth rate (CAGR) of 7.3%. The substantial growth during the historical period can be credited to the use of telemedicine and remote monitoring, the discovery…
Myocardial Infarction Treatment Market Growth and Insights 2024
"The Business Research Company recently released a comprehensive report on the Global Myocardial Infarction Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry. Ready to Dive into Something Exciting? Get Your Free Exclusive Sample…
Myocardial Infarction Drugs Market
According to a new report published by Allied Market Research, titled, "Myocardial Infarction Drugs Market by Product Type (Analgesics, Antiplatelet Agents, Vasodilators, Thrombolytics, Anti-Thrombotic Agents, Glycoprotein IIb/IIIa Inhibitors, Î' Adrenergic Blockers, Angiotensin Receptor Blockers, and Angiotensin Converting Enzyme Inhibitors) and by Distribution Channel (Hospital Pharmacies, Hospitals, Drug Stores, and Online Drug Stores) - Global Opportunity Analysis and Industry Forecast, 2019-2026". The Global market size of Myocardial Infarction Drugs Market was $XX…
Myocardial Ischemia - Pipeline Review, H1 2017 - Pharmaceutical Report
Lack of blood flow and oxygen to the heart muscle lead to cardiac ischemia, also called myocardial ischemia. The signs and symptoms may include chest pain, typically on the left side of the body (angina pectoris), neck or jaw pain, shoulder or arm pain, clammy skin, shortness of breath and nausea and vomiting. Myocardial ischemia can be caused by conditions such as coronary artery disease (atherosclerosis), blood clot, coronary spasm…